Advanced Search

Show simple item record

dc.contributor.authorBayındır, Osman
dc.contributor.authorAkpınar, Belhhan
dc.contributor.authorCan, Erol
dc.contributor.authorGüden, Mustafa
dc.contributor.authorSönmez, Bingür
dc.contributor.authorDemiroğlu, Cemşid
dc.description.abstractObjective:To evaluate the effect of the 5-HT3-receptor antagonist ondansetron in patients with postcardiotomy delirium. Design: Prospective study. Setting: University hospital. Participants: Thirty-five patients who had undergone coronary artery bypass graft surgery. Interventions: Thirty-five patients 23 men and 12 women who developed delirium in the intensive care unit after coronary artery bypass graft surgery were included. Mean patient age was 51.3 years (range 36 to 79 years). A mental status scoring scale was developed and patients were scored 0 to 4 according to their delirium status after confirming that there were no correctable metabolic abnormalities as an underlying cause for delirium. Normal behavior was scored as 0 and severe verbal and physical agitation was scored as 4. Patients received a single dose of ondansetron 8 mg intravenously and were reevaluated 10 minutes later. Measurements and Main Results: Before the treatment 7 patients had a score of 2 (20)en_US]
dc.description.abstract10 patients (28.6%) 3en_US]
dc.description.abstractand 18 patients (51.4%) 4. After the treatment 28 patients (80%) dropped their score to 0en_US]
dc.description.abstract6 patients (17.1%) dropped to a score of 1 and 1 patient (2.9%) remained at a score of 4. The mean score dropped from 3.20 + 1.01 to 0.29 + 0.75 after treatment. Wilcoxon signed ranks test was used for statistical evaluation and the fall in delirium score after ondansetron treatment was found to be statistically significant (p < 0.001). Conclusions: The use of ondansetron was effective and safe and without important side effects. This positive effect of the 5-HT3-receptor antagonist ondansetron led to speculation that impaired serotonin metabolism may play a role in postcardiotomy delirium. Copyright (C) 2000 by W.B. Saunders Company.en_US]
dc.publisherW.B. Saunders Co Ltden_US
dc.subjectPostcardiotomy deliriumen_US
dc.subject5-HT3-receptor antagonismen_US
dc.titleThe use of the 5-HT3-receptor antagonist ondansetron for the treatment of postcardiotomy deliriumen_US
dc.relation.journalJournal of Cardiothoracic and Vascular Anesthesiaen_US
dc.institutionauthorBayındır, Osmanen_US
dc.institutionauthorAkpınar, Belhhanen_US
dc.institutionauthorCan, Erolen_US
dc.institutionauthorGüden, Mustafaen_US
dc.institutionauthorSönmez, Bingüren_US
dc.institutionauthorDemiroğlu, Cemşiden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record